Max Robotics — Global Service Robot Directory + US Certification

About

David Pistenmaa is a leading figure in the advancement of precision radiation oncology, with a career dedicated to minimizing treatment toxicity while maximizing therapeutic efficacy. His key research areas encompass stereotactic radiosurgery, stereotactic body radiation therapy (SBRT), and cost-effectiveness in cancer care. A major contribution is his pioneering work on robotically guided radiosurgery for pediatric patients, demonstrating that frameless, high-precision techniques can spare children the cognitive decline associated with whole-brain radiotherapy. This seminal 2004 study, with 54 citations, helped establish a new standard for treating pediatric brain tumors. Pistenmaa also applies rigorous health economics to radiation oncology, as seen in his 2011 Markov model analysis comparing SBRT to IMRT for prostate cancer, a study that, despite its modest citation count, reflects his commitment to value-based care. His work bridges the gap between cutting-edge technology and practical, patient-centered outcomes, influencing how clinicians balance efficacy, toxicity, and cost. Through these contributions, Pistenmaa has shaped the evolution of safer, more targeted radiation treatments for vulnerable populations.